Epigenetic regulation of EBV persistence and oncogenesis

Seminars in Cancer Biology

Volumn 26, Issue , 2014, Pages 22-29

  Tempera, Italo ^a   Lieberman, Paul M ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

Chromatin; Chromosome conformation; CTCF; DNA methylation; Epstein Barr virus; Gammaherpesvirus; Histone modifications; OriP

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 2; HISTONE ACETYLTRANSFERASE PCAF; LATENCY ASSOCIATED PEPTIDE; LMP1 PROTEIN; LMP2 PROTEIN; RBP JK PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; CHROMATIN; HISTONE; ORIP PROTEIN; REGULATOR PROTEIN;

BINDING SITE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA CONFORMATION; DNA METHYLATION; EBV GENE; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENETIC STABILITY; GENETIC VARIABILITY; HETEROCHROMATIN; HISTONE MODIFICATION; HUMAN; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; TRANSCRIPTION INITIATION SITE; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS LATENCY; CELL TRANSFORMATION; CHROMATIN; COMPLICATION; DNA REPLICATION ORIGIN; EPSTEIN BARR VIRUS INFECTION; GENETIC EPIGENESIS; GENETICS; INSULATOR ELEMENT; METABOLISM; NEOPLASMS; PHYSIOLOGY; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS GENOME; CHROMOSOME ANALYSIS; EPIGENETICS; GENE EXPRESSION; IMMUNE EVASION; PERSISTENT VIRUS INFECTION; VIRAL TROPISM;

CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HISTONES; HUMANS; INSULATOR ELEMENTS; NEOPLASMS; REPLICATION ORIGIN; VIRUS LATENCY;

EID: 84901829406     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.01.003     Document Type: Review

References (115)

1. Kieff E. Epstein-Barr virus and its replication 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia.
2. Young L.S., Rickinson A.B. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757-768.
3. Howlader N.N.A., Krapcho M., Neyman N., Aminou R., Altekruse S.F., Kosary C.L., et al. SEER Cancer Statistics Review, 1975-2009 (vintage 2009 populations) 2011, National Cancer Institute, Bethesda, MD.
4. Babcock G.J., Hochberg D., Thorley-Lawson A.D. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000, 13:497-506.
5. Rowe M., Lear A.L., Croom-Carter D., Davies A.H., Rickinson A.B. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 1992, 66:122-131.
6. Thorley-Lawson D.A., Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004, 350:1328-1337.
7. Qu L., Rowe D.T. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol 1992, 66:3715-3724.
8. Tierney R.J., Steven N., Young L.S., Rickinson A.B. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994, 68:7374-7385.
9. Woisetschlaeger M., Yandava C.N., Furmanski L.A., Strominger J.L., Speck S.H. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci U S A 1990, 87:1725-1729.
10. Nonkwelo C., Skinner J., Bell A., Rickinson A., Sample J. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J Virol 1996, 70:623-627.
11. Tierney R., Kirby H., Nagra J., Rickinson A., Bell A. The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5. J Virol 2000, 74:10458-10467.
12. Hughes D.J., Dickerson C.A., Shaner M.S., Sample C.E., Sample J.T. trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency. J Virol 2011, 85:11435-11447.
13. Tempera I., Lieberman P.M. Chromatin organization of gammaherpesvirus latent genomes. Biochim Biophys Acta 2009.
14. Nishikawa J., Kis L.L., Liu A., Zhang X., Takahara M., Bandobashi K., et al. Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line. Virus Genes 2004, 28:121-128.
15. Masucci M.G., Contreras-Salazar B., Ragnar E., Falk K., Minarovits J., Ernberg I., et al. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. J Virol 1989, 63:3135-3141.
16. Dyson P.J., Farrell P.J. Chromatin structure of Epstein-Barr virus. J Gen Virol 1985, 66(Pt 9):1931-1940.
17. Wensing B., Stuhler A., Jenkins P., Hollyoake M., Karstegl C.E., Farrell P.J. Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP. J Virol 2001, 75:6235-6241.
18. Woellmer A., Hammerschmidt W. Epstein-Barr virus and host cell methylation: regulation of latency, replication and virus reactivation. Curr Opin Virol 2013, 3:260-265.
19. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
20. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
21. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
22. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007, 39:311-318.
23. Peters A.H., Mermoud J.E., O'Carroll D., Pagani M., Schweizer D., Brockdorff N., et al. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat Genet 2002, 30:77-80.
24. Mermoud J.E., Popova B., Peters A.H., Jenuwein T., Brockdorff N. Histone H3 lysine 9 methylation occurs rapidly at the onset of random X chromosome inactivation. Curr Biol 2002, 12:247-251.
25. Cao R., Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 2004, 14:155-164.
26. Arvey A., Tempera I., Tsai K., Chen H.S., Tikhmyanova N., Klichinsky M., et al. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe 2012, 12:233-245.
27. Gerle B., Koroknai A., Fejer G., Bakos A., Banati F., Szenthe K., et al. Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells. J Virol 2007, 81:13242-13247.
28. Tempera I., Wiedmer A., Dheekollu J., Lieberman P.M. CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLoS Pathog 2010, 6:e1001048.
29. Day L., Chau C.M., Nebozhyn M., Rennekamp A.J., Showe M., Lieberman P.M. Chromatin profiling of Epstein-Barr virus latency control region. J Virol 2007, 81:6389-6401.
30. Arvey A., Tempera I., Lieberman P.M. Interpreting the Epstein-Barr virus (EBV) epigenome using high-throughput data. Viruses 2013, 5:1042-1054.
31. Murata T., Kondo Y., Sugimoto A., Kawashima D., Saito S., Isomura H., et al. Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells. J Virol 2012, 86:4752-4761.
32. Ramasubramanyan S., Osborn K., Flower K., Sinclair A.J. Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome. J Virol 2012, 86:1809-1819.
33. Toth Z., Brulois K., Jung J.U. The chromatin landscape of Kaposi's sarcoma-associated herpesvirus. Viruses 2013, 5:1346-1373.
34. Toth Z., Maglinte D.T., Lee S.H., Lee H.R., Wong L.Y., Brulois K.F., et al. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog 2010, 6:e1001013.
35. Jin B., Tao Q., Peng J., Soo H.M., Wu W., Ying J., et al. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Hum Mol Genet 2008, 17:690-709.
36. Robertson K.D. DNA methylation and human disease. Nat Rev Genet 2005, 6:597-610.
37. Gopalakrishnan S., Van Emburgh B.O., Robertson K.D. DNA methylation in development and human disease. Mutat Res 2008, 647:30-38.
38. Robertson K.D., Manns A., Swinnen L.J., Zong J.C., Gulley M.L., Ambinder R.F. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease. Blood 1996, 88:3129-3136.
39. Paulson E.J., Fingeroth J.D., Yates J.L., Speck S.H. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. Virology 2002, 299:109-121.
40. Robertson K.D., Ambinder R.F. Methylation of the Epstein-Barr virus genome in normal lymphocytes. Blood 1997, 90:4480-4484.
41. Kintner C., Sugden B. Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells. J Virol 1981, 38:305-316.
42. Jansson A., Masucci M., Rymo L. Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines. J Virol 1992, 66:62-69.
43. Bakos A., Banati F., Koroknai A., Takacs M., Salamon D., Minarovits-Kormuta S., et al. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1. Virus Genes 2007, 35:195-202.
44. Salamon D., Takacs M., Schwarzmann F., Wolf H., Minarovits J., Niller H.H. High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes. Virus Genes 2003, 27:57-66.
45. Paulson E.J., Speck S.H. Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J Virol 1999, 73:9959-9968.
46. Lehnertz B., Ueda Y., Derijck A.A., Braunschweig U., Perez-Burgos L., Kubicek S., et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003, 13:1192-1200.
47. Takacs M., Salamon D., Myohanen S., Li H., Segesdi J., Ujvari D., et al. Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes. Biol Chem 2001, 382:699-705.
48. Falk K.I., Szekely L., Aleman A., Ernberg I. Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP). J Virol 1998, 72:2969-2974.
49. Tao Q., Robertson K.D., Manns A., Hildesheim A., Ambinder R.F. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive. J Virol 1998, 72:7075-7083.
50. Leonard S., Wei W., Anderton J., Vockerodt M., Rowe M., Murray P.G., et al. Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma. J Virol 2011, 85:9568-9577.
51. Hughes D.J., Marendy E.M., Dickerson C.A., Yetming K.D., Sample C.E., Sample J.T. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency. J Virol 2012, 86:1034-1045.
52. Chau C.M., Lieberman P.M. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 2004, 78:12308-12319.
53. Chevallier-Greco A., Manet E., Chavrier P., Mosnier C., Daillie J., Sergeant A. Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J 1986, 5:3243-3249.
54. Zalani S., Holley-Guthrie E., Kenney S. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci U S A 1996, 93:9194-9199.
55. Ramasubramanyan S., Kanhere A., Osborn K., Flower K., Jenner R.G., Sinclair A.J. Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile. J Virol 2012, 86:12494-12502.
56. Bergbauer M., Kalla M., Schmeinck A., Gobel C., Rothbauer U., Eck S., et al. CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog 2010, 6:e1001114.
57. Bhende P.M., Seaman W.T., Delecluse H.J., Kenney S.C. The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat Genet 2004, 36:1099-1104.
58. Yu X., Wang Z., Mertz J.E. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. PLoS Pathog 2007, 3:e194.
59. Filippova G.N., Fagerlie S., Klenova E.M., Myers C., Dehner Y., Goodwin G., et al. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol Cell Biol 1996, 16:2802-2813.
60. Phillips J.E., Corces V.G. CTCF: master weaver of the genome. Cell 2009, 137:1194-1211.
61. Ohlsson R., Renkawitz R., Lobanenkov V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 2001, 17:520-527.
62. Holdorf M.M., Cooper S.B., Yamamoto K.R., Miranda J.J. Occupancy of chromatin organizers in the Epstein-Barr virus genome. Virology 2011, 415:1-5.
63. Chau C.M., Zhang X.Y., McMahon S.B., Lieberman P.M. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol 2006, 80:5723-5732.
64. Salamon D., Banati F., Koroknai A., Ravasz M., Szenthe K., Bathori Z., et al. Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity. J Gen Virol 2009, 90:1183-1189.
65. Majumder P., Boss J.M. CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus. Mol Cell Biol 2010, 30:4211-4223.
66. Splinter E., Heath H., Kooren J., Palstra R.J., Klous P., Grosveld F., et al. CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus. Genes Dev 2006, 20:2349-2354.
67. Sanyal A., Lajoie B.R., Jain G., Dekker J. The long-range interaction landscape of gene promoters. Nature 2012, 489:109-113.
68. Fraser P., Bickmore W. Nuclear organization of the genome and the potential for gene regulation. Nature 2007, 447:413-417.
69. Tempera I., Klichinsky M., Lieberman P.M. EBV latency types adopt alternative chromatin conformations. PLoS Pathog 2011, 7:e1002180.
70. Rubio E.D., Reiss D.J., Welcsh P.L., Disteche C.M., Filippova G.N., Baliga N.S., et al. CTCF physically links cohesin to chromatin. Proc Natl Acad Sci U S A 2008, 105:8309-8314.
71. Stedman W., Kang H., Lin S., Kissil J.L., Bartolomei M.S., Lieberman P.M. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J 2008, 27:654-666.
72. Wendt K.S., Yoshida K., Itoh T., Bando M., Koch B., Schirghuber E., et al. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 2008, 451:796-801.
73. Nasmyth K., Haering C.H. The structure and function of SMC and kleisin complexes. Annu Rev Biochem 2005, 74:595-648.
74. Gruber S., Haering C.H., Nasmyth K. Chromosomal cohesin forms a ring. Cell 2003, 112:765-777.
75. Zhang N., Kuznetsov S.G., Sharan S.K., Li K., Rao P.H., Pati D. A handcuff model for the cohesin complex. J Cell Biol 2008, 183:1019-1031.
76. Zhou J., Chau C.M., Deng Z., Shiekhattar R., Spindler M.P., Schepers A., et al. Cell cycle regulation of chromatin at an origin of DNA replication. EMBO J 2005, 24:1406-1417.
77. Avolio-Hunter T.M., Frappier L. EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication. Virology 2003, 315:398-408.
78. Iizuka M., Stillman B. Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the human initiator protein. J Biol Chem 1999, 274:23027-23034.
79. Pak D.T., Pflumm M., Chesnokov I., Huang D.W., Kellum R., Marr J., et al. Association of the origin recognition complex with heterochromatin and HP1 in higher eukaryotes. Cell 1997, 91:311-323.
80. Altmann M., Pich D., Ruiss R., Wang J., Sugden B., Hammerschmidt W. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc Natl Acad Sci U S A 2006, 103:14188-14193.
81. Nilsson T., Zetterberg H., Wang Y.C., Rymo L. Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. J Virol 2001, 75:5796-5811.
82. Puglielli M.T., Woisetschlaeger M. Speck SH. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol 1996, 70:5758-5768.
83. Reisman D., Sugden B. Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol 1986, 6:3838-3846.
84. Sugden B., Warren N. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol 1989, 63:2644-2649.
85. Takacs M., Banati F., Koroknai A., Segesdi J., Salamon D., Wolf H., et al. Epigenetic regulation of latent Epstein-Barr virus promoters. Biochim Biophys Acta 2010, 1799:228-235.
86. Grosveld F., van Assendelft G.B., Greaves D.R., Kollias G. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell 1987, 51:975-985.
87. Li Q., Peterson K.R., Fang X., Stamatoyannopoulos G. Locus control regions. Blood 2002, 100:3077-3086.
88. Tolhuis B., Palstra R.J., Splinter E., Grosveld F., de Laat W. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell 2002, 10:1453-1465.
89. Frappier L., O'Donnell M. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci U S A 1991, 88:10875-10879.
90. Wang L., Grossman S.R., Kieff E. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc Natl Acad Sci U S A 2000, 97:430-435.
91. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996, 384:641-643.
92. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
93. Blanco J.C., Minucci S., Lu J., Yang X.J., Walker K.K., Chen H., et al. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev 1998, 12:1638-1651.
94. Wu D.Y., Kalpana G.V., Goff S.P., Schubach W.H. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1. J Virol 1996, 70:6020-6028.
95. Palermo R.D., Webb H.M., West M.J. RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus. PLoS Pathog 2011, 7:e1002334.
96. Paschos K., Allday M.J. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol 2010, 18:439-447.
97. Valk-Lingbeek M.E., Bruggeman S.W., van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004, 118:409-418.
98. Macdiarmid J., Stevenson D., Campbell D.H., Wilson J.B. The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo. Carcinogenesis 2003, 24:1209-1218.
99. Chong J.M., Sakuma K., Sudo M., Ushiku T., Uozaki H., Shibahara J., et al. Global and non-random CpG-island methylation in gastric carcinoma associated with Epstein-Barr virus. Cancer Sci 2003, 94:76-80.
100. Kang G.H., Lee S., Kim W.H., Lee H.W., Kim J.C., Rhyu M.G., et al. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 2002, 160:787-794.
101. Tsai C.L., Li H.P., Lu Y.J., Hsueh C., Liang Y., Chen C.L., et al. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res 2006, 66:11668-11676.
102. Hino R., Uozaki H., Murakami N., Ushiku T., Shinozaki A., Ishikawa S., et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 2009, 69:2766-2774.
103. Marquitz A.R., Raab-Traub N. The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol 2012, 22:166-172.
104. Lin I.G., Tomzynski T.J., Ou Q., Hsieh C.L. Modulation of DNA binding protein affinity directly affects target site demethylation. Mol Cell Biol 2000, 20:2343-2349.
105. Kamranvar S.A., Chen X., Masucci M.G. Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus. Oncogene 2013, 32:5522-5530.
106. Kamranvar S.A., Masucci M.G. The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia 2011, 25:1017-1025.
107. Lu F., Wikramasinghe P., Norseen J., Tsai K., Wang P., Showe L., et al. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1). Virol J 2010, 7:262.
108. Canaan A., Haviv I., Urban A.E., Schulz V.P., Hartman S., Zhang Z., et al. EBNA1 regulates cellular gene expression by binding cellular promoters. Proc Natl Acad Sci U S A 2009, 106:22421-22426.
109. Sompallae R., Callegari S., Kamranvar S.A., Masucci M.G. Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes. PLoS ONE 2010, 5:e12052.
110. Dresang L.R., Vereide D.T., Sugden B. Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. J Virol 2009, 83:2930-2940.
111. Wang S., Frappier L. Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation. J Virol 2009, 83:11704-11714.
112. Zhou J., Chau C., Deng Z., Stedman W., Lieberman P.M. Epigenetic control of replication origins. Cell Cycle 2005, 4:889-892.
113. Avolio-Hunter T.M., Lewis P.N., Frappier L. Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication. Nucleic Acids Res 2001, 29:3520-3528.
114. Coppotelli G., Mughal N., Callegari S., Sompallae R., Caja L., Luijsterburg M.S., et al. The Epstein-Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins. Nucleic Acids Res 2013, 41:2950-2962.
115. Gruhne B., Sompallae R., Marescotti D., Kamranvar S.A., Gastaldello S., Masucci M.G. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci U S A 2009, 106:2313-2318.